Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Constellation Brands Inc. Common Stock (STZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Constellation Brands Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Constellation Brands Inc. Common Stock trades at $127.6 (market cap $21.50B). The key difference: Constellation Brands Inc. Common Stock is far larger — about 2.4× Kymera Therapeutics Inc. Common Stock's market cap, and Constellation Brands Inc. Common Stock pays a 3.24% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KYMR | STZ | |
|---|---|---|
Market Cap | $8.87B | $21.50B |
Volume | 779,107 | 2,104,680 |
Sector | Health | Consumer Staples |
52-Week High | $127.31 | $166.68 |
52-Week Low | $55.80 | $112.77 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $8.26B | $31.72B |
Dividend Yield | — | 3.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Constellation Brands Inc. Common Stock
Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →
